In routine UK hospital practice T-SPOT.TB™ is useful in some patients with a modest pre-test probability of active tuberculosis.

Lance Turtle; Tim Kemp; Geraint R. Davies; Bertie Squire; Nicholas Beeching; Michael B.J. Beadsworth

doi:10.1016/j.ejim.2012.01.002

In routine UK hospital practice T-SPOT.TB™ is useful in some patients with a modest pre-test probability of active tuberculosis.

Lance Turtle
, Tim Kemp
, Geraint R. Davies
, Bertie Squire
, Nicholas Beeching
, Michael B.J. Beadsworth

Liverpool University Hospitals NHS Foundation Trust

Research output: Contribution to journal › Article › peer-review

7 Citations (Scopus)

Abstract

Although it can add weight to a clinical diagnosis, T-SPOT.TB™ assay is not reliable for the diagnosis of active tuberculosis in a real world setting where the test is often used in patients with smear negative or extra-pulmonary disease. The test is useful for ruling out disease in HIV negative patients.

Original language	English
Pages (from-to)	363-367
Number of pages	5
Journal	European Journal of Internal Medicine
Volume	23
Issue number	4
DOIs	https://doi.org/10.1016/j.ejim.2012.01.002
Publication status	Published - 1 Jun 2012
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

ELISpot
Interferon-gamma release assay
Sensitivity and specificity
Tuberculosis

Access to Document

10.1016/j.ejim.2012.01.002

Cite this

@article{aaaaf82282d1497eb6fcce0a0d6dc201,

title = "In routine UK hospital practice T-SPOT.TB{\texttrademark} is useful in some patients with a modest pre-test probability of active tuberculosis.",

abstract = "Although it can add weight to a clinical diagnosis, T-SPOT.TB{\texttrademark} assay is not reliable for the diagnosis of active tuberculosis in a real world setting where the test is often used in patients with smear negative or extra-pulmonary disease. The test is useful for ruling out disease in HIV negative patients.",

keywords = "ELISpot, Interferon-gamma release assay, Sensitivity and specificity, Tuberculosis",

author = "Lance Turtle and Tim Kemp and Davies, \{Geraint R.\} and Bertie Squire and Nicholas Beeching and Beadsworth, \{Michael B.J.\}",

year = "2012",

month = jun,

day = "1",

doi = "10.1016/j.ejim.2012.01.002",

language = "English",

volume = "23",

pages = "363--367",

journal = "European Journal of Internal Medicine",

issn = "0953-6205",

publisher = "Elsevier B.V.",

number = "4",

}

TY - JOUR

T1 - In routine UK hospital practice T-SPOT.TB™ is useful in some patients with a modest pre-test probability of active tuberculosis.

AU - Turtle, Lance

AU - Kemp, Tim

AU - Davies, Geraint R.

AU - Squire, Bertie

AU - Beeching, Nicholas

AU - Beadsworth, Michael B.J.

PY - 2012/6/1

Y1 - 2012/6/1

N2 - Although it can add weight to a clinical diagnosis, T-SPOT.TB™ assay is not reliable for the diagnosis of active tuberculosis in a real world setting where the test is often used in patients with smear negative or extra-pulmonary disease. The test is useful for ruling out disease in HIV negative patients.

AB - Although it can add weight to a clinical diagnosis, T-SPOT.TB™ assay is not reliable for the diagnosis of active tuberculosis in a real world setting where the test is often used in patients with smear negative or extra-pulmonary disease. The test is useful for ruling out disease in HIV negative patients.

KW - ELISpot

KW - Interferon-gamma release assay

KW - Sensitivity and specificity

KW - Tuberculosis

U2 - 10.1016/j.ejim.2012.01.002

DO - 10.1016/j.ejim.2012.01.002

M3 - Article

SN - 0953-6205

VL - 23

SP - 363

EP - 367

JO - European Journal of Internal Medicine

JF - European Journal of Internal Medicine

IS - 4

ER -

In routine UK hospital practice T-SPOT.TB™ is useful in some patients with a modest pre-test probability of active tuberculosis.

Abstract

UN SDGs

Keywords

Access to Document

Fingerprint

Cite this